Regent Investment Management LLC Decreases Position in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)


Share on StockTwits

Regent Investment Management LLC lowered its stake in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 0.4% in the 1st quarter, HoldingsChannel reports. The firm owned 48,191 shares of the pharmacy operator’s stock after selling 194 shares during the quarter. Regent Investment Management LLC’s holdings in Walgreens Boots Alliance were worth $2,646,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Enterprise Trust & Investment Co increased its stake in shares of Walgreens Boots Alliance by 48.9% during the 4th quarter. Enterprise Trust & Investment Co now owns 75,550 shares of the pharmacy operator’s stock worth $3,623,000 after purchasing an additional 24,800 shares during the last quarter. Cambridge Financial Group Inc. grew its stake in Walgreens Boots Alliance by 8.7% in the 4th quarter. Cambridge Financial Group Inc. now owns 131,126 shares of the pharmacy operator’s stock valued at $5,229,000 after buying an additional 10,500 shares in the last quarter. Unison Advisors LLC grew its stake in Walgreens Boots Alliance by 1.3% in the 4th quarter. Unison Advisors LLC now owns 42,432 shares of the pharmacy operator’s stock valued at $1,693,000 after buying an additional 544 shares in the last quarter. Stifel Financial Corp grew its stake in Walgreens Boots Alliance by 19.1% in the 4th quarter. Stifel Financial Corp now owns 1,030,045 shares of the pharmacy operator’s stock valued at $41,078,000 after buying an additional 165,435 shares in the last quarter. Finally, Equity Investment Corp grew its stake in Walgreens Boots Alliance by 19.1% in the 4th quarter. Equity Investment Corp now owns 1,410,706 shares of the pharmacy operator’s stock valued at $56,259,000 after buying an additional 225,973 shares in the last quarter. Institutional investors own 55.96% of the company’s stock.

Walgreens Boots Alliance stock traded down $0.91 during mid-day trading on Thursday, hitting $53.14. The company’s stock had a trading volume of 58,990 shares, compared to its average volume of 6,366,581. The company has a debt-to-equity ratio of 0.58, a current ratio of 0.67 and a quick ratio of 0.32. The stock has a market cap of $45.93 billion, a price-to-earnings ratio of 108.10, a price-to-earnings-growth ratio of 1.52 and a beta of 0.44. The business has a 50 day moving average price of $52.61 and a 200-day moving average price of $45.05. Walgreens Boots Alliance, Inc. has a 12 month low of $33.36 and a 12 month high of $57.05.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings data on Tuesday, March 30th. The pharmacy operator reported $1.40 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.10 by $0.30. Walgreens Boots Alliance had a net margin of 0.33% and a return on equity of 18.33%. The firm had revenue of $32.78 billion for the quarter, compared to analysts’ expectations of $36.16 billion. During the same quarter in the previous year, the company earned $1.52 earnings per share. The company’s revenue for the quarter was down 8.5% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 4.84 earnings per share for the current fiscal year.

The business also recently declared a quarterly dividend, which was paid on Friday, March 12th. Investors of record on Friday, February 19th were given a dividend of $0.4675 per share. This represents a $1.87 annualized dividend and a dividend yield of 3.52%. The ex-dividend date of this dividend was Thursday, February 18th. Walgreens Boots Alliance’s dividend payout ratio is currently 39.45%.

A number of research firms recently weighed in on WBA. Robert W. Baird upgraded shares of Walgreens Boots Alliance from a “neutral” rating to an “outperform” rating and lifted their price objective for the company from $41.00 to $55.00 in a research note on Monday, January 11th. Truist Securities lifted their price objective on shares of Walgreens Boots Alliance from $50.00 to $58.00 in a research note on Thursday, April 1st. Guggenheim raised shares of Walgreens Boots Alliance from a “neutral” rating to a “buy” rating and set a $55.00 price target for the company in a report on Monday, January 11th. Royal Bank of Canada raised their price target on shares of Walgreens Boots Alliance from $44.00 to $52.00 in a report on Thursday, April 1st. Finally, Mizuho raised their price target on shares of Walgreens Boots Alliance from $37.00 to $47.00 and gave the company a “neutral” rating in a report on Monday, January 11th. Two analysts have rated the stock with a sell rating, eleven have given a hold rating and two have assigned a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus price target of $49.06.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and beauty retail company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, wellness, beauty, personal care, consumable, and general merchandise products through its retail drugstores.

Further Reading: What is the NASDAQ Stock Market?

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance, Inc. (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.